Richard D Moore Selected Research

Art Therapy

1/2022	Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?
1/2022	Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD.
1/2022	Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV.
1/2021	Longitudinal Associations of Syndemic Conditions with Antiretroviral Therapy Adherence and HIV Viral Suppression Among HIV-Infected Patients in Primary Care.
1/2021	Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus.
1/2020	Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
1/2020	Cervical cancer risk in women living with HIV across four continents: A multicohort study.
11/2019	Censoring for Loss to Follow-up in Time-to-event Analyses of Composite Outcomes or in the Presence of Competing Risks.
4/2019	Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus.
1/2019	One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Moore Research Topics

Disease

56	Acquired Immunodeficiency Syndrome (AIDS) 10/2022 - 07/2002
27	HIV Infections (HIV Infection) 10/2020 - 01/2002
25	Infections 01/2021 - 01/2002
19	Substance-Related Disorders (Drug Abuse) 02/2022 - 03/2002
16	Coinfection 01/2022 - 08/2003
14	Neoplasms (Cancer) 01/2022 - 02/2008
14	Viremia 01/2021 - 02/2004
10	Disease Progression 01/2019 - 03/2003
9	Hepatitis C 12/2020 - 01/2002
6	Hypertension (High Blood Pressure) 01/2022 - 12/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
6	Hepatitis 01/2022 - 01/2002
6	Syphilis 12/2020 - 06/2008
6	Myocardial Infarction 10/2020 - 01/2017
6	Fibrosis (Cirrhosis) 04/2019 - 01/2005
5	Alcoholism (Alcohol Abuse) 01/2022 - 03/2002
5	Sepsis (Septicemia) 01/2021 - 01/2017
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 05/2010
5	Tuberculosis (Tuberculoses) 01/2017 - 07/2007
4	COVID-19 03/2022 - 10/2021
4	Chronic Renal Insufficiency 01/2022 - 09/2012
4	Marijuana Use 12/2021 - 01/2017
4	Weight Gain 10/2021 - 01/2016
4	Hepatitis B 01/2021 - 11/2004
4	Obesity 03/2020 - 03/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 11/2007
4	Kidney Diseases (Kidney Disease) 09/2017 - 12/2007
4	Liver Diseases (Liver Disease) 07/2012 - 10/2003
4	Opportunistic Infections (Opportunistic Infection) 08/2011 - 12/2003
3	End Stage Liver Disease 01/2022 - 07/2012
3	Stroke (Strokes) 01/2021 - 01/2019
3	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017 - 10/2015
3	Inflammation (Inflammations) 01/2017 - 01/2011
3	Overweight 10/2016 - 03/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 10/2003
3	Lymphoma (Lymphomas) 07/2014 - 08/2013
3	Mental Disorders (Mental Disorder) 05/2009 - 12/2004
2	Anus Neoplasms (Anal Cancer) 01/2022 - 01/2020
2	Diabetes Mellitus 10/2021 - 01/2021
2	Ischemic Stroke 01/2021 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2019
2	Noncommunicable Diseases 01/2019 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 07/2003
2	Persistent Infection 10/2017 - 12/2012
2	Acute Kidney Injury (Acute Renal Failure) 09/2017 - 07/2017
2	Bacteremia 01/2017 - 10/2003
2	Immune Reconstitution Inflammatory Syndrome 07/2014 - 12/2007
2	Herpes Zoster 10/2012 - 10/2005
2	Hepatocellular Carcinoma (Hepatoma) 07/2012 - 10/2003
2	Anemia 11/2011 - 01/2002

Drug/Important Bio-Agent (IBA)

35	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2002
32	Pharmaceutical PreparationsIBA 03/2022 - 01/2002
11	Cocaine (Cocaine HCl)IBA 02/2022 - 03/2002
7	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 03/2006
5	Opioid Analgesics (Opioids)IBA 12/2021 - 06/2010
5	efavirenz (Sustiva)FDA Link 10/2021 - 01/2002
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 01/2002
4	CholesterolIBA 01/2022 - 01/2011
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 01/2017
4	Crack CocaineIBA 01/2022 - 01/2017
4	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2006
4	Heroin (Diamorphine)IBA 01/2021 - 03/2002
4	Oxygen (Dioxygen)IBA 01/2021 - 01/2017
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 02/2008
3	Integrase InhibitorsIBA 10/2021 - 01/2020
3	Raltegravir Potassium FDA Link 10/2021 - 01/2014
3	abacavir (Ziagen)FDA Link 01/2021 - 02/2008
3	Tenofovir (Viread)FDA Link 01/2021 - 02/2008
3	N-acetoacetyl-N-deacetylcolchicineIBA 05/2020 - 02/2008
3	Reverse Transcriptase InhibitorsIBA 01/2020 - 08/2003
3	AntigensIBA 01/2020 - 11/2015
3	NucleosidesIBA 01/2020 - 02/2004
3	Biological ProductsIBA 04/2016 - 11/2002
2	N-nitrosoiminodiacetic acidIBA 03/2022 - 02/2022
2	BilirubinIBA 01/2022 - 01/2019
2	Darunavir (Prezista)FDA Link 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2017
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2020
2	Serum AlbuminIBA 01/2022 - 02/2006
2	dolutegravirIBA 10/2021 - 01/2021
2	IntegrasesIBA 10/2021 - 01/2021
2	Emtricitabine (Emtriva)FDA Link 01/2021 - 06/2017
2	LipidsIBA 10/2020 - 11/2015
2	InterferonsIBA 04/2019 - 01/2017
2	Viral RNAIBA 01/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2018 - 01/2011
2	insulin receptor-related receptor (IRR)IBA 04/2015 - 10/2003
2	Alanine Transaminase (SGPT)IBA 12/2014 - 03/2014
2	Indicators and Reagents (Reagents)IBA 01/2014 - 10/2003
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 06/2008
2	CI 22IBA 10/2013 - 12/2012
2	Hemoglobins (Hemoglobin)IBA 01/2011 - 01/2002

Therapy/Procedure

64	Therapeutics 01/2022 - 01/2002
44	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 01/2002
37	Art Therapy 01/2022 - 11/2004
7	Retention in Care 10/2022 - 06/2012
5	Continuity of Patient Care 01/2021 - 01/2016
3	Critical Care (Surgical Intensive Care) 01/2022 - 10/2003
2	Ambulatory Care (Outpatient Care) 12/2008 - 11/2008